Caredx (CDNA)

Company Profile

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients.

Company profile

Ticker

CDNA

Exchange

NASDAQ

Website

www.caredx.com

CEO

Peter Maag

Incorporated

Delaware

Location

California

Fiscal year end

Dec 31

Sector

Health Care and Social Assistance > Medical Laboratories

Industry (SIC)

Services - Medical Laboratories

Quest Diagnostics • Laboratory Corp. Of America • Akumin • Radnet • Burning Rock Biotech • Guardant Health • Genomic Health • Invitae • Natera • Exact Sciences ...

Former names

EXPRESSION DIAGNOSTICS INC, XDx, Inc.

SEC CIK

0001217234

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

CareDx International AB • CareDx AB • CareDx Lab Solutions, Inc. • CareDx Transplant Management, Inc. • CareDx GmbH • CareDx Pty Ltd. • MedActionPlan.com LLC ...

CDNA stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$26.00

Low target

$24.00

High target

$28.00

BTIG

Maintains

Buy

$28.00

7 Nov 22

Latest filings (excl ownership)

View all

8-K

CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022

9 Jan 23

8-K

CareDx Announces $50 Million Stock Repurchase Program

6 Dec 22

8-K

Departure of Directors or Certain Officers

23 Nov 22

8-K

CareDx Reports Third Quarter 2022 Results

3 Nov 22

Departure of Directors or Certain Officers

7 Sep 22

8-K

Departure of Directors or Certain Officers

4 Aug 22

CareDx Reports Second Quarter 2022 Results

4 Aug 22

8-K

Submission of Matters to a Vote of Security Holders

17 Jun 22

Transcripts

View all

CDNA

Earnings call transcript

2022 Q3

4 Nov 22

CDNA

Earnings call transcript

2022 Q2

7 Aug 22

CDNA

Earnings call transcript

2022 Q1

6 May 22

CDNA

Earnings call transcript

2021 Q4

25 Feb 22

CDNA

Earnings call transcript

2021 Q3

29 Oct 21

CDNA

Earnings call transcript

2021 Q2

30 Jul 21

CDNA

Earnings call transcript

2021 Q1

6 May 21

CDNA

Earnings call transcript

2020 Q4

25 Feb 21

CDNA

Earnings call transcript

2020 Q3

1 Nov 20

CDNA

Earnings call transcript

2020 Q3

29 Oct 20

Latest ownership filings

View all

Financial summary

Financial statements Chart CDNA financial data

Quarter (USD)	Sep 22	Jun 22	Mar 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	83.16 mm	83.16 mm	83.16 mm	83.16 mm	83.16 mm	83.16 mm
Cash burn (monthly)	27.96 mm	22.51 mm	5.78 mm	6.32 mm	2.36 mm	2.35 mm
Cash used (since last report)	118.08 mm	95.07 mm	24.41 mm	26.68 mm	9.97 mm	9.95 mm
Cash remaining	-34.92 mm	-11.91 mm	58.75 mm	56.48 mm	73.19 mm	73.21 mm
Runway (months of cash)	-1.2	-0.5	10.2	8.9	31.0	31.1

Beta Read what these cash burn values mean

Financial data from Caredx earnings reports.

Institutional ownership, Q3 2022

CDNA institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	180	185	-2.7%
Opened positions	23	27	-14.8%
Closed positions	28	54	-48.1%
Increased positions	71	78	-9.0%
Reduced positions	55	48	+14.6%

13F shares	Current	Prev Q	Change
Total value	903.22 mm	1.25 bn	-27.6%
Total shares	57.00 mm	62.15 mm	-8.3%
Total puts	17.40 k	51.10 k	-65.9%
Total calls	35.70 k	47.70 k	-25.2%
Total put/call ratio	0.5	1.1	-54.5%

Largest owners	Shares	Value	Change
ARK Investment Management	5.79 mm	$98.50 mm	+44.8%
Vanguard	5.07 mm	$86.21 mm	+1.6%
BLK Blackrock	4.01 mm	$68.28 mm	+1.8%
Alger Associates	3.27 mm	$0.00	0.0%
ArrowMark Colorado	3.09 mm	$52.57 mm	+7.0%
BLVGF Bellevue	2.60 mm	$44.28 mm	+2.5%
CMTDF Sumitomo Mitsui Trust	2.49 mm	$42.33 mm	+14.5%
Nikko Asset Management Americas	2.49 mm	$40.74 mm	+14.5%
Fred Alger Management	1.98 mm	$33.72 mm	-31.4%
Clearbridge Advisors	1.66 mm	$28.32 mm	+0.5%

Largest transactions	Shares	Bought/sold	Change
STT State Street	0.00	-4.21 mm	EXIT
IVZ Invesco	70.62 k	-1.91 mm	-96.4%
ARK Investment Management	5.79 mm	+1.79 mm	+44.8%
Fred Alger Management	1.98 mm	-908.07 k	-31.4%
Assenagon Asset Management	116.08 k	-885.41 k	-88.4%
Intrinsic Edge Capital Management	0.00	-585.65 k	EXIT
Bamco	1.62 mm	+582.87 k	+56.1%
D. E. Shaw & Co.	875.23 k	+389.62 k	+80.2%
Conestoga Capital Advisors	580.53 k	-369.17 k	-38.9%
MCQEF Macquarie	1.60 mm	-342.98 k	-17.6%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

CDNA insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
3 Feb 23	Alexander L Johnson	Common Stock	Payment of exercise	Dispose F	No	No	16.54	417	6.90 k	197,169
3 Feb 23	Alexander L Johnson	Common Stock	Payment of exercise	Dispose F	No	No	16.54	417	6.90 k	197,586
3 Feb 23	Reginald Seeto	Common Stock	Payment of exercise	Dispose F	No	No	16.54	1,228	20.31 k	566,103
3 Feb 23	Reginald Seeto	Common Stock	Payment of exercise	Dispose F	No	No	16.54	1,228	20.31 k	567,331
2 Feb 23	Alexander L Johnson	Common Stock	Payment of exercise	Dispose F	No	No	17.61	2,029	35.73 k	198,003
2 Feb 23	Reginald Seeto	Common Stock	Payment of exercise	Dispose F	No	No	17.61	7,244	127.57 k	568,559
2 Feb 23	Reginald Seeto	Common Stock	Sell	Dispose S	No	Yes	17.5047	503	8.80 k	575,803
2 Feb 23	Reginald Seeto	Common Stock	Sell	Dispose S	No	Yes	17.0733	2,316	39.54 k	576,306
2 Feb 23	Peter Maag	Common Stock	Sell	Dispose S	No	Yes	17.1659	5,000	85.83 k	298,737
1 Feb 23	Alexander L Johnson	Common Stock	Payment of exercise	Dispose F	No	No	15.66	618	9.68 k	200,032